Moleculin Biotech is trading at $0.40 (6.2% down) in after-hours sessions, extending volatility following its recent $9.3 million discounted public offering.
- The stock initially stabilized during the regular session, rising 6.25% to $0.42, before reversing those gains in thinner after-hours trading.
- Market sentiment remains pressured as investors continue to digest the impact of share dilution and the potential overhang from newly issued warrants.